Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 11,196Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4AstraZeneca Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AstraZeneca Canada Inc.

arrow
Coatings Trends
Not Confirmed

AstraZeneca Canada Inc.

Country
arrow
Coatings Trends
Not Confirmed

CAPIVASERTIB

Brand Name : TRUQAP

Patent Number : 2701057

Filing Date : 2008-10-09

Strength per Unit : 160 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-10-09

Date Granted : 2015-03-24

blank

02

AstraZeneca Canada Inc.

arrow
Coatings Trends
Not Confirmed

AstraZeneca Canada Inc.

Country
arrow
Coatings Trends
Not Confirmed

CAPIVASERTIB

Brand Name : TRUQAP

Patent Number : 2869936

Filing Date : 2013-04-16

Strength per Unit : 160 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-04-16

Date Granted : 2020-07-28

blank

03

AstraZeneca Canada Inc.

arrow
Coatings Trends
Not Confirmed

AstraZeneca Canada Inc.

Country
arrow
Coatings Trends
Not Confirmed

CAPIVASERTIB

Brand Name : TRUQAP

Patent Number : 2701057

Filing Date : 2008-10-09

Strength per Unit : 200 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-10-09

Date Granted : 2015-03-24

blank

04

AstraZeneca Canada Inc.

arrow
Coatings Trends
Not Confirmed

AstraZeneca Canada Inc.

Country
arrow
Coatings Trends
Not Confirmed

CAPIVASERTIB

Brand Name : TRUQAP

Patent Number : 2869936

Filing Date : 2013-04-16

Strength per Unit : 200 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-04-16

Date Granted : 2020-07-28

blank